1. Acknowledgement to Referees

   ACKNOWLEDGEMENT TO REFEREES 30 October 2019 Pages: 725 - 727

2. Predictability of Capillary Blood Spot Toward Venous Whole Blood Sampling for Therapeutic Drug Monitoring of Tacrolimus in Solid Organ Transplant Recipients

   • Jaryd Gallant
   • Jenny Wichart
   • Tony K. L. Kiang

   Current Opinion 22 April 2019 Pages: 729 - 741

   

3. Current Understanding of the Equivalence Evaluations for In Vitro Tests on Generic Dry Powder Inhaler Drug Products in Japan

   • Ryosuke Kuribayashi
   • Aya Myoenzono
   • Mitsue Hirota

   Current Opinion 06 May 2019 Pages: 743 - 745

   

4. Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies

   • Christian Zurth
   • Mikko Koskinen
   • Hille Gieschen

   Original Research Article Open access 30 September 2019 Pages: 747 - 759

   

5. Effect of Dietary Doses of Quercetin on Hepatic Drug Metabolizing Enzymes in Spontaneously Hypertensive Rats

   • Fawzy Elbarbry
   • Aimy Ung
   • Khaled Abdelkawy

   Original Research Article 07 May 2019 Pages: 761 - 770

   

6. The Effects of CYP3A5 Genetic Polymorphisms on Serum Tacrolimus Dose-Adjusted Concentrations and Long-Term Prognosis in Chinese Heart Transplantation Recipients

   • Bing-yang Liu
   • Wen-qian Chen
   • Sheng-shou Hu

   Original Research Article 13 May 2019 Pages: 771 - 776

   

7. Dose Escalation Study to Assess the Pharmacokinetic Parameters of a Nano-amorphous Oral Sirolimus Formulation in Healthy Volunteers

   • Orsolya Basa-Dénes
   • Réka Angi
   • Hristos Glavinas

   Original Research Article 14 May 2019 Pages: 777 - 785

   

8. Inhibition of Rat CYP1A2 and CYP2C11 by Honokiol, a Component of Traditional Chinese Medicine

   • Jing Li
   • Ming-rui Li
   • Na Gao

   Original Research Article 07 June 2019 Pages: 787 - 796

   

9. Effects of UGT1A1 Polymorphism, Gender and Triglyceride on the Pharmacokinetics of Telmisartan in Chinese Patients with Hypertension: A Population Pharmacokinetic Analysis

   • Lu Huang
   • Liu Yang
   • Qi Pei

   Original Research Article 28 June 2019 Pages: 797 - 806

   

10. Clinical Pharmacokinetics of Vancomycin in Critically Ill Children

    • Kannan Sridharan
    • Amal Al Daylami
    • Sindhan Veeramuthu

    Original Research Article 12 July 2019 Pages: 807 - 816

    

11. Further Assessment of the Relay Hepatocyte Assay for Determination of Intrinsic Clearance of Slowly Metabolised Compounds Using Radioactivity Monitoring and LC–MS Methods

    • Renata Murgasova

    Original Research Article 17 August 2019 Pages: 817 - 826

    

12. Effects of Animal Strain, Dose, and Cotreatment with Saikosaponin b₂ on the Pharmacokinetics of Saikosaponin a in Rats

    • Ruijia Fu
    • Jingjing Liu
    • Rui Song

    Short Communication 17 July 2019 Pages: 827 - 836

    

13. Vancomycin Pharmacokinetics in Patients with Advanced Cancer Near End of Life

    • Hirokazu Nakayama
    • Masahiro Suzuki
    • Hirotoshi Echizen

    Short Communication 01 June 2019 Pages: 837 - 843

14. Cerebrospinal Fluid Drug Concentrations and Clinical Outcome of Patients with Neoplastic Meningitis Treated with Liposomal Cytarabine

    • Jan-Paul Bohn
    • Vera Reinstadler
    • Dominik Wolf

    Short Communication Open access 22 August 2019 Pages: 845 - 851

    

15. Retraction Note to: Identification of CYP3A4 as the primary cytochrome P450 responsible for the metabolism of tandospirone by human liver microsomes

    • Kiyohi Natsui
    • Yoshiko Mizuno
    • Setsuko Komuro

    Retraction Note 23 October 2019 Pages: 853 - 853